c-ABL-IN-4 structure
|
Common Name | c-ABL-IN-4 | ||
---|---|---|---|---|
CAS Number | 2626934-68-5 | Molecular Weight | 409.75 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C18H11ClF3N3O3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of c-ABL-IN-4c-ABL-IN-4 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-4 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2021048567A1, compound 54)[1]. |
Name | c-ABL-IN-4 |
---|
Description | c-ABL-IN-4 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-4 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2021048567A1, compound 54)[1]. |
---|---|
Related Catalog | |
References |
[1]. Michael J. RAWLING, et al. New compounds and methods. Patent WO2021048567A1. |
Molecular Formula | C18H11ClF3N3O3 |
---|---|
Molecular Weight | 409.75 |